Kiritkumar Patel, MD
Cardiovascular Disease · Bloomfield Hills, MINPI 1003871294
Payments from drug & device makers
Across 397 payments — averaging $1702.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$601K
- Shockwave Medical, Inc$40K
- Boehringer Ingelheim International GmbH$23K
- Boehringer Ingelheim Pharma GmbH & Co.kg$7K
- Endologix LLC$1K
- Abbott$1K
- plus $3K from 33 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 189 | $600,613 |
| Shockwave Medical, Inc | 19 | $39,644 |
| Boehringer Ingelheim International GmbH | 15 | $23,116 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 1 | $6,677 |
| Endologix LLC | 44 | $1,453 |
| Abbott | 33 | $1,430 |
| Bolton Medical Inc | 3 | $554 |
| Abiomed | 5 | $487 |
| Novartis | 13 | $304 |
| Kestra Medical Technology Services, Inc. | 9 | $241 |
| Biotronik Inc. | 2 | $183 |
| Edwards Lifesciences | 2 | $183 |
| Lexicon Pharmaceuticals, Inc. | 3 | $138 |
| E.r. Squibb & Sons, L.L.C. | 15 | $131 |
| Baxter Healthcare | 2 | $89 |
| Pfizer | 4 | $82 |
| Amgen | 4 | $64 |
| Cleerly, Inc. | 2 | $64 |
| Merck | 3 | $62 |
| Johnson & Johnson | 4 | $55 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $50 |
| Heartflow, Inc. | 1 | $47 |
| Sanofi-aventis U.S. LLC | 2 | $33 |
| Boston Scientific | 2 | $27 |
| AstraZeneca | 2 | $25 |
| Novo Nordisk | 1 | $25 |
| Actelion Pharmaceuticals US, Inc. | 1 | $24 |
| Cvrx, Inc. | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $20 |
| Terumo Medical Corporation | 1 | $19 |
| Atricure, Inc. | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Bayer | 1 | $16 |
| Cordis US CORP. | 1 | $15 |
| Penumbra, Inc. | 1 | $13 |
| Cardinal Health 200 LLC | 1 | $12 |
| W. L. Gore & Associates, Inc. | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Vantis Vascular, Inc. | 1 | $0 |
How this compares
$675,974 in reported general payments places this provider in the 95th percentile of 760 cardiovascular disease providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Bloomfield Hills
- Michele DegregorioBloomfield Hills$153K
- Stanley ChetcutiAnn Arbor$4.3M
- Sandeep KhuranaGrandville$2.3M
- Victor MolesAnn Arbor$2.1M
- Jihad MustaphaGrand Rapids$1.9M
- Marschall RungeAnn Arbor$1.8M
- Sara SaberiAnn Arbor$1.6M
- Brian OneillDetroit$1.4M
- Vallerie McLaughlinAnn Arbor$1.4M
- Ahmad MizyedYpsilanti$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.